These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39034205)

  • 1. Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program.
    Dew A; Lin J; Darmon S; Roswarski J; Shriver C; Zhu K; Chiu A
    Clin Lymphoma Myeloma Leuk; 2024 Nov; 24(11):789-795. PubMed ID: 39034205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
    Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
    Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
    Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
    Lin J; McGlynn KA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
    Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Lin J; Hu H; Shriver CD; Zhu K
    Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status.
    Lin J; Shriver CD; Zhu K
    Cancer Causes Control; 2024 Jan; 35(1):21-31. PubMed ID: 37532916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
    Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
    Anderson AB; Kim E; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
    J Am Acad Orthop Surg; 2024 Jul; 32(13):e651-e660. PubMed ID: 38684126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
    Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
    Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
    Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
    Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry.
    Flanary JT; Lin J; Shriver CD; Zhu K
    Cancer Med; 2023 Nov; 12(22):20989-21000. PubMed ID: 37902129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
    Anderson AB; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
    J Am Acad Orthop Surg Glob Res Rev; 2022 Jun; 6(6):. PubMed ID: 35727910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence rates of bladder and kidney cancers among US military servicemen: comparison with the rates in the general US population.
    Bytnar JA; McGlynn KA; Kern SQ; Shriver CD; Zhu K
    Eur J Cancer Prev; 2024 Nov; 33(6):505-511. PubMed ID: 38568164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.
    Bytnar JA; Enewold L; Shriver CD; Zhu K
    Cancer Epidemiol; 2024 Apr; 89():102539. PubMed ID: 38340498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence rates of oral cavity and oropharyngeal cancers among men: a comparison of active-duty military and general populations.
    Bytnar JA; Shriver CD; Zhu K
    Eur J Cancer Prev; 2022 Mar; 31(2):166-171. PubMed ID: 33990095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer incidence in the US military: An updated analysis.
    Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
    Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER.
    Lin J; Orestes MI; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):426-434. PubMed ID: 38099827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in the U.S. military population: comparison with rates from the SEER program.
    Zhu K; Devesa SS; Wu H; Zahm SH; Jatoi I; Anderson WF; Peoples GE; Maxwell LG; Granger E; Potter JF; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1740-5. PubMed ID: 19505907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence rates of digestive cancers among U.S. military servicemen: Comparison with the rates in the general U.S. population.
    Bytnar JA; Shriver CD; Zhu K
    PLoS One; 2021; 16(9):e0257087. PubMed ID: 34478468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.